YIELM Trademark
Trademark Overview
On Tuesday, August 16, 2022, a trademark application was filed for YIELM with the United States Patent and Trademark Office. The USPTO has given the YIELM trademark a serial number of 97550251. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, July 21, 2025. This trademark is owned by Eli Lilly and Company. The YIELM trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascula...
General Information
| Serial Number | 97550251 |
| Word Mark | YIELM |
| Filing Date | Tuesday, August 16, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Monday, July 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 20, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 6, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Friday, August 19, 2022 | NEW APPLICATION ENTERED |
| Tuesday, September 6, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 17, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 17, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 31, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 20, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 20, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 15, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 16, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, January 16, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, January 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 16, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, July 16, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 16, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 16, 2025 | SOU EXTENSION 3 FILED |
| Thursday, January 16, 2025 | SOU EXTENSION 3 GRANTED |
| Thursday, January 16, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 21, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 21, 2025 | SOU EXTENSION 4 FILED |
| Monday, July 21, 2025 | SOU EXTENSION 4 GRANTED |
| Tuesday, July 22, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 17, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 12, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 12, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 12, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
